Skip to main content
Caplight Logo









Medcura, Inc.

Medcura, Inc.

Private
MarylandHealthcare & Life Scienceshttps://www.medcurainc.com/

Last Round

Series B

Jul 20, 2025

Total Funding Raised

$43.3M

Company Overview

Medcura, Inc. is a medical device company that develops and commercializes a portfolio of hemostatic products designed to control bleeding in surgical, medical, and consumer applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials, Defense Tech

Business Model

B2B2C

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

hemostatic agentbleeding controlsurgical hemostatbiopolymer platformnon-swelling hemostatMedTechadvanced wound careflowable hemostatabsorbable hemostatchitosan-based hemostattrauma medicineover-the-counter wound carecombat casualty careBreakthrough Device Designationveterinary wound care

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Medcura, Inc. Comparables

Compare Medcura, Inc. with similar companies based on industry and business-model similarity.

Medcura, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cresilon
82%
Hemostasis, LLC
81%
Marine Polymer Technologies
80%

Medcura, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 20, 2025
Convertible DebtApr 3, 2024
GrantSep 8, 2022
Series AAug 12, 2021
Private PlacementJul 13, 2017

Key People

Founding team and executive leadership

Jim Buck

President & CEO

Executive Team

Medcura, Inc. Investors

Notable investors and investment history

Medcura, Inc. investors
InvestorRounds
TEDCOGrant
UM VenturesPrivate Placement

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2025

    $13M round closed

  • Jul 8, 2025

    Monthly visitors increased 48% MoM, reaching 3.4K.

Medcura, Inc. Filings

Explore SEC and related filing metadata, where available.

Medcura, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Medcura, Inc.'s valuation, stock price, and market status.

Is Medcura, Inc. a public or private company?

Medcura, Inc. is a private company.

What is the current stock price of Medcura, Inc.?

Medcura, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Medcura, Inc. worth (valuation)?

Valuation information for Medcura, Inc. is not publicly available.

Can I buy Medcura, Inc. stock?

Medcura, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Medcura, Inc.'s last funding round?

Medcura, Inc.'s most recent funding round was Series B on July 20, 2025.

Who are the main investors in Medcura, Inc.?

Key investors in Medcura, Inc. include TEDCO, UM Ventures.

Will Medcura, Inc. IPO soon?

No public IPO plans have been announced for Medcura, Inc..

How can I track Medcura, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Medcura, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMaryland
Employee Range30
Year Founded2007
Last FundingJul 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?